Free shipping on all orders over $ 500

IWR-1-endo

Cat. No. M2782

All AbMole products are for research use only, cannot be used for human consumption.

IWR-1-endo Structure
Synonym:

endo-IWR 1; IWR-1

Size Price Availability Quantity
5mg USD 48  USD48 In stock
10mg USD 78  USD78 In stock
25mg USD 174  USD174 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

IWR-1 (endo-IWR 1) is a Wnt pathway inhibitor with IC50 of 180 nM, induces Axin2 protein levels and promotes β-catenin phosphorylation by stabilizing Axin-scaffolded destruction complexes.

Product Citations
Customer Product Validations & Biological Datas
Source Sci Rep (2017). Figure 3. IWR-1-endo
Method qPCR
Cell Lines EMSC osteogenic
Concentrations 10 μM
Incubation Time 24 h
Results To further study whether the Wnt/β-catenin pathway is involved in regulating EMSC osteogenic differentiation, we treated EMSCs with the Wnt signalling inhibitor IWR-1-endo and the Wnt signalling agonist SKL2001 before osteogenic induction.
Chemical Information
Molecular Weight 409.44
Formula C25H19N3O3
CAS Number 1127442-82-3
Solubility (25°C) DMSO 30 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Jia Sun, et al. aFGF alleviates diabetic endothelial dysfunction by decreasing oxidative stress via Wnt/β-catenin-mediated upregulation of HXK2

[2] Wei Wang, et al. IWR-1 Inhibits Collagen-Induced Platelet Activation and Protects against Thrombogenesis

[3] Carl T Gustafson, et al. Efflux inhibition by IWR-1-endo confers sensitivity to doxorubicin effects in osteosarcoma cells

[4] Ming-Wei Zhou, et al. Inhibition of collagen synthesis by IWR-1 in normal and keloid-derived skin fibroblasts

[5] Sang Chul Lee, et al. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression

Related Wnt/beta-catenin Products
(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide

(9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide is a macamide isolated from Maca (Lepidium meyenii Walp). (9Z,12Z,15Z)-N-[(3-Methoxyphenyl)methyl]-9,12,15-octadecatrienamide induces mesenchymal stem cells osteogenic differentiation and consequent bone formation through activating the canonical Wnt/β‐catenin signaling pathway.

F7H

F7H is a Frizzled receptor FZD7 antagonist with IC50 of 1.25 μM. F7H is a potent ligand for the FZD7 transmembrane domain (TMD).

UU-T02

UU-T02 is a novel potent, selective small-molecule inhibitor of β-Catenin/T-cell factor protein-protein interaction, with a Ki of 1.36 μM. UU-T02 inhibits canonical Wnt signaling.

Wnt/β-catenin agonist 1

Wnt/β-catenin agonist 1 is a Wnt/β-catenin signalling pathway agonist, with an EC50 of 0.27 μM.

Calphostin C

Calphostin C (PKF115-584) is a small molecule inhibitor of Wnt/beta-catenin/lef-1 signaling. Calphostin C is also a potent and specific inhibitor of protein kinase C. PKF115-584 efficiently killed CLL cells (LC(50)<1 microM), whereas normal B cells were not significantly affected.

  Catalog
Abmole Inhibitor Catalog




Keywords: IWR-1-endo, endo-IWR 1; IWR-1 supplier, Wnt/beta-catenin, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.